Mepiform is a brand of thin, discreet, self-adherent soft silicone dressings manufactured by Mölnlycke Health Care. It is designed specifically for the management and prevention of old and new hypertrophic and keloid scars.
Core Technology and Composition
Mepiform utilizes patented Safetac® technology, which is a soft silicone adhesive layer. This technology is clinically proven to minimize pain and skin trauma during dressing changes because it adheres gently without sticking to the wound area or stripping the skin upon removal.
The dressing consists of two main layers:
Backing:
A breathable, showerproof laminate made of polyurethane film and viscose nonwoven fabric.
Contact Layer:
Medical-grade soft silicone adhesive (Safetac).
Key Product Benefits
Scar Reduction:
Helps flatten, soften, and fade red and raised scars resulting from surgery, accidents, cuts, or burns.
Discreet Design:
The thin, flexible material conforms to body contours and is suitable for wear under clothing during daily activities.
UV Protection:
Features an UV protection factor (UPF) of class 5 to protect healing scars from sunlight-induced discoloration.
Ease of Use:
Mepiform is waterproof, allowing users to bathe or shower without removal. It can also be cut to specific sizes to fit various scar shapes.
Reusability:
A single sheet can typically be worn for several days (often 3 to 7 days) and can be reapplied after daily skin cleaning.
Clinical Usage and Application
Mepiform is intended for use on closed wounds to prevent future scarring or on existing mature/immature scars.
Wear Time:
For optimal results, it should be worn 24 hours a day. It should be removed once daily for skin inspection and cleaning.
Treatment Duration:
Prophylactic treatment usually lasts 2 to 6 months. Improving old scars may take from 3 months to over a year.
Safety:
It is suitable for use on children when used as directed.
Manufacturer Overview
Mepiform is produced by Mölnlycke Health Care, a world-leading global provider of single-use surgical and wound care products. The company focuses on innovative solutions that minimize community and hospital-acquired conditions while providing value for money supported by clinical evidence.